首页 | 本学科首页   官方微博 | 高级检索  
检索        

晚期非小细胞肺癌伴恶性胸腔积液的双介入治疗探讨
引用本文:宋太民,孙玉枝.晚期非小细胞肺癌伴恶性胸腔积液的双介入治疗探讨[J].中国临床医学影像杂志,1999,10(5):331-333.
作者姓名:宋太民  孙玉枝
作者单位:河南漯河市第一人民医院介入放射科!河南漯河,462000,河南漯河市第一人民医院介入放射科!河南漯河,462000,河南漯河市第一人民医院介入放射科!河南漯河,462000,河南漯河市第一人民医院介入放射科!河南漯河,462000,河南漯河市第一人民医院介入放射科!河南漯河,462000,河南漯河市
摘    要:目的:评价选择性支气管动脉灌注化疗(BAI)和胸腔内灌注化疗(PLI)联合治疗晚期非小细胞肺癌(NSCLC)伴恶性胸腔积液(MPE)的疗效。材料和方法:30例病变局限于胸部的晚期NSCLC伴MPE患者。

关 键 词:肺肿瘤  恶性胸腔积液  介入治疗

The double interventional therapy of advanced non-small cell lung carcinoma and malignant pleural effusion
SONG Tai-min,SUN Yu-zhi,ZHANG Yao-yong,HAN Zhao-yu,ZHANG Li-ping,ZHANG Jin-an.The double interventional therapy of advanced non-small cell lung carcinoma and malignant pleural effusion[J].Journal of China Clinic Medical Imaging,1999,10(5):331-333.
Authors:SONG Tai-min  SUN Yu-zhi  ZHANG Yao-yong  HAN Zhao-yu  ZHANG Li-ping  ZHANG Jin-an
Abstract:Objective:To evaluate the effect of the combinational therapy of bronchial artery infusion(BAI)and pleural transluminal infusion(PLI)of advanced non-small cell lung carcinoma(NSCLC)with malignant pleural efffusin (MPE).Materials and Methods:Thirty patients with advanced NSCLC and MPE (Tumor only in chest)were treated with PLI 2-7days after treated with BAI.Results:Efficiency of treatment of tumor in lungs or MPE was 86.7% or 93.3% respectively.The survival rate of 6 months,1 year or 2 years was 93.3%,63.3% or 30% respectively.Conclusion:It is an effective therapy in treatment of advanced NSCLC with MPE with combination of BAI and PLI.
Keywords:Lung neolpasms  Malignant pleural effusion  Interventional therapy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号